Nodal T-cell Lymphoma with Tfh Phenotype

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-06
Clinical Trial Update: A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype [Phase 3]
This is a Phase 3 trial comparing duvelisib to Gemcitabine or Bendamustine in relapsed/refractory nodal T-cell lymphoma with TFH phenotype. …